News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
169,135 Results
Type
Article (15857)
Company Profile (13)
Press Release (153265)
Multimedia
Podcasts (1)
Webinars (3)
Section
Business (45972)
Career Advice (227)
Deals (6533)
Drug Delivery (18)
Drug Development (21990)
Employer Resources (26)
FDA (3482)
Job Trends (3610)
News (77343)
Policy (6386)
Tag
2024 BioCapital Digital (1)
2024 BioForest Digital (1)
2024 Biotech Bay Standard (1)
Academia (1760)
Accelerated approval (1)
Adcomms (11)
Allergies (14)
Alliances (14401)
ALS (25)
Alzheimer's disease (519)
Antibody-drug conjugate (ADC) (26)
Approvals (3485)
Artificial intelligence (84)
Autoimmune disease (1)
Automation (5)
Bankruptcy (45)
Best Places to Work (3077)
BIOSECURE Act (14)
Biosimilars (10)
Biotechnology (15)
Bladder cancer (19)
Brain cancer (10)
Breast cancer (101)
Cancer (708)
Cardiovascular disease (41)
Career advice (210)
Career pathing (4)
CAR-T (43)
Cell therapy (105)
Cervical cancer (10)
Clinical research (17083)
Collaboration (230)
Compensation (20)
Complete response letters (5)
COVID-19 (1181)
CRISPR (12)
C-suite (66)
Cystic fibrosis (27)
Data (538)
Depression (4)
Diabetes (42)
Diagnostics (1798)
Digital health (3)
Diversity (2)
Diversity, equity & inclusion (9)
Drug discovery (32)
Drug pricing (21)
Drug shortages (1)
Duchenne muscular dystrophy (17)
Earnings (11243)
Editorial (7)
Employer branding (3)
Employer resources (21)
Events (22134)
Executive appointments (181)
FDA (3751)
Featured Employer (2)
Friedreich's ataxia (2)
Frontotemporal dementia (3)
Funding (309)
Gene editing (23)
Generative AI (2)
Gene therapy (92)
GLP-1 (147)
Government (1284)
Guidances (13)
Healthcare (5502)
Huntington's disease (1)
IgA nephropathy (1)
Immunology and inflammation (16)
Indications (4)
Infectious disease (1217)
Inflammatory bowel disease (37)
Inflation Reduction Act (2)
Influenza (6)
Intellectual property (16)
Interviews (23)
IPO (3225)
IRA (12)
Job creations (636)
Job search strategy (198)
Kidney cancer (5)
Labor market (7)
Layoffs (69)
Leadership (1)
Legal (1212)
Liver cancer (24)
Lung cancer (104)
Lymphoma (40)
Machine learning (3)
Management (7)
Manufacturing (56)
MASH (11)
Medical device (2928)
Medtech (2928)
Mergers & acquisitions (3472)
Metabolic disorders (80)
Multiple sclerosis (18)
NASH (4)
Neurodegenerative disease (19)
Neuropsychiatric disorders (3)
Neuroscience (648)
NextGen: Class of 2025 (1796)
Non-profit (1995)
Northern California (514)
Now hiring (5)
Obesity (29)
Opinion (49)
Ovarian cancer (31)
Pain (21)
Pancreatic cancer (24)
Parkinson's disease (36)
Partnered (8)
Patents (47)
Patient recruitment (28)
Peanut (9)
People (17202)
Pharmaceutical (6)
Phase I (5579)
Phase II (7777)
Phase III (5406)
Pipeline (258)
Policy (48)
Postmarket research (662)
Preclinical (2530)
Press Release (19)
Prostate cancer (30)
Psychedelics (11)
Radiopharmaceuticals (60)
Rare diseases (88)
Real estate (1376)
Recruiting (11)
Regulatory (4350)
Reports (9)
Research institute (1926)
Resumes & cover letters (19)
Rett syndrome (1)
RNA editing (1)
RSV (6)
Schizophrenia (14)
Series A (49)
Series B (20)
Service/supplier (1)
Sickle cell disease (19)
Southern California (464)
Spinal muscular atrophy (29)
Sponsored (2)
Startups (1190)
Stomach cancer (3)
Supply chain (13)
Tariffs (3)
The Weekly (1)
United States (4972)
Vaccines (259)
Venture capitalists (11)
Weight loss (12)
Women's health (3)
Worklife (3)
Date
Last 7 days (127)
Last 30 days (588)
Last 365 days (8014)
2025 (2222)
2024 (8626)
2023 (10102)
2022 (13382)
2021 (14936)
2020 (13837)
2019 (12785)
2018 (9360)
2017 (8579)
2016 (8492)
2015 (9881)
2014 (7329)
2013 (6020)
2012 (6057)
2011 (6378)
2010 (5741)
Location
Africa (207)
Alabama (32)
Alaska (3)
Arizona (61)
Arkansas (5)
Asia (9781)
Australia (2205)
California (1195)
Canada (804)
China (79)
Colorado (52)
Connecticut (49)
Delaware (36)
Europe (22624)
Florida (220)
Georgia (28)
Idaho (11)
Illinois (127)
India (5)
Indiana (57)
Japan (42)
Kansas (24)
Kentucky (11)
Louisiana (1)
Maine (9)
Maryland (173)
Massachusetts (842)
Michigan (27)
Minnesota (75)
Missouri (26)
Montana (10)
Nebraska (5)
Nevada (6)
New Hampshire (14)
New Jersey (491)
New Mexico (7)
New York (426)
North Carolina (169)
North Dakota (3)
Northern California (514)
Ohio (51)
Oklahoma (5)
Oregon (8)
Pennsylvania (285)
Puerto Rico (1)
Rhode Island (8)
South America (269)
South Carolina (5)
Southern California (464)
Tennessee (24)
Texas (240)
Utah (37)
Virginia (27)
Washington D.C. (37)
Washington State (178)
West Virginia (1)
Wisconsin (10)
169,135 Results for "van andel institute".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Corvus Pharmaceuticals Appoints Richard A. van den Broek to Board of Directors
April 10, 2025
·
4 min read
Press Releases
Sensorion Announces its Participation at the Van Lanschot Kempen Conference Life Sciences
March 26, 2025
·
3 min read
Press Releases
Schrödinger Expands Board of Directors with Appointment of Bridget van Kralingen
March 10, 2025
·
4 min read
Press Releases
Innate Pharma announces its participation in the Life Sciences Van Lanschot Kempen Conference
March 25, 2025
·
4 min read
Press Releases
Valneva to Present at Upcoming TD Cowen and Van Lanschot Kempen Healthcare Investor Conferences
March 3, 2025
·
4 min read
Machine Learning
Opinion: Smart Antibodies Will Transform Our Fight Against Solid Tumors
AI is enabling the development of a next generation of drugs that can more precisely target cancer cells while sparing healthy tissues.
April 14, 2025
·
4 min read
·
Gino Van Heeke
Press Releases
AcuraStem Welcomes Dr. Marcel van der Brug as Chief Scientific Officer
December 5, 2024
·
3 min read
Business
mAbxience Appoints Jurgen Van Broeck as New CEO
mAbxience, a Fresenius Kabi majority-owned group with partial ownership from Insud Pharma, is pleased to announce the appointment of Jurgen Van Broeck as Chief Executive Officer.
May 9, 2024
·
2 min read
Press Releases
Renovaro Inc. Appoints Maurice van Tilburg to Lead GEDi Cube BV
December 30, 2024
·
5 min read
Press Releases
Science 37 Appoints Tyler Van Horn as CEO to Lead Next Era of Patient-Access Innovation
January 14, 2025
·
2 min read
1 of 16,914
Next
